JAFRON(SZ:300529) Sou Hu Cai Jing·2025-07-07 09:39Company Overview - Jianfan Biological Technology Group Co., Ltd. specializes in the research, production, and sales of biomaterials and high-tech medical devices [2] - The main products include various blood perfusion devices, dialysis solutions, disinfectants, and blood purification equipment [2] - The company has received multiple accolades, including being recognized as a key high-tech enterprise under the National Torch Program and a national champion in manufacturing [2] Financial Performance - For Q1 2025, the company reported a revenue of 548 million yuan, a year-on-year decrease of 26.40% [2] - The net profit for the same period was 189 million yuan, down 33.71% year-on-year, with a gross profit margin of 80.74% [2] Market Position - As of July 7, the company's stock closed at 22.84 yuan, with a rolling price-to-earnings (PE) ratio of 25.19 times [1] - The average PE ratio for the medical device industry is 51.42 times, with a median of 37.44 times, placing Jianfan Biological at the 55th position in the industry ranking [1][3] Capital Flow - On July 7, the net outflow of main funds for Jianfan Biological was 14.63 million yuan, although there was a total inflow of 46.86 million yuan over the past five days [1]